251 related articles for article (PubMed ID: 24889617)
1. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
[TBL] [Abstract][Full Text] [Related]
2. MEK drives cyclin D1 hyperelevation during geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
[TBL] [Abstract][Full Text] [Related]
3. Gerosuppression in confluent cells.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2014 Dec; 6(12):1010-8. PubMed ID: 25585637
[TBL] [Abstract][Full Text] [Related]
4. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2013 Sep; 12(18):3063-9. PubMed ID: 23974099
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
7. Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.
Leontieva OV; Blagosklonny MV
Oncotarget; 2014 Dec; 5(24):12715-27. PubMed ID: 25587030
[TBL] [Abstract][Full Text] [Related]
8. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
Demidenko ZN; Blagosklonny MV
Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
[TBL] [Abstract][Full Text] [Related]
9. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
Leontieva OV; Demidenko ZN; Blagosklonny MV
Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence.
Poulsen RC; Watts AC; Murphy RJ; Snelling SJ; Carr AJ; Hulley PA
Ann Rheum Dis; 2014 Jul; 73(7):1405-13. PubMed ID: 23727633
[TBL] [Abstract][Full Text] [Related]
11. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
13. Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma.
Ji WT; Yang SR; Chen JY; Cheng YP; Lee YR; Chiang MK; Chen HR
Cancer Sci; 2012 Jul; 103(7):1221-9. PubMed ID: 22469187
[TBL] [Abstract][Full Text] [Related]
14. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
Khor ES; Wong PF
Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
[TBL] [Abstract][Full Text] [Related]
15. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16.
Sung JY; Lee KY; Kim JR; Choi HC
Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
Anandharaj A; Cinghu S; Park WY
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and gerosuppression: the mTOR saga continues.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2012 Nov; 11(21):3926-31. PubMed ID: 22987149
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
He L; Guo S; Zhu T; Chen C; Xu K
Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
[TBL] [Abstract][Full Text] [Related]
20. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate.
Romanov VS; Abramova MV; Svetlikova SB; Bykova TV; Zubova SG; Aksenov ND; Fornace AJ; Pospelova TV; Pospelov VA
Cell Cycle; 2010 Oct; 9(19):3945-55. PubMed ID: 20935470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]